nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—vagus nerve—coronary artery disease	0.0614	0.902	CbGeAlD
Fosaprepitant—TACR1—blood—coronary artery disease	0.00664	0.0976	CbGeAlD
Fosaprepitant—Aprepitant—CYP2C19—coronary artery disease	0.00471	1	CrCbGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL4—coronary artery disease	0.000404	0.00129	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.000403	0.00128	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.000402	0.00128	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MAPK1—coronary artery disease	0.000397	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—UTS2—coronary artery disease	0.000397	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—ADRB2—coronary artery disease	0.000393	0.00125	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TMED2—coronary artery disease	0.000388	0.00124	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PLCB3—coronary artery disease	0.000384	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—P2RY12—coronary artery disease	0.000384	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.000382	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CASR—coronary artery disease	0.00038	0.00121	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—coronary artery disease	0.000378	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AVPR1A—coronary artery disease	0.000373	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000373	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GNA12—coronary artery disease	0.000373	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—coronary artery disease	0.000371	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP8—coronary artery disease	0.000371	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DGKZ—coronary artery disease	0.000371	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RLN3—coronary artery disease	0.000371	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	0.000368	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADM—coronary artery disease	0.000363	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—UTS2—coronary artery disease	0.00036	0.00115	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDN2—coronary artery disease	0.000355	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AES—coronary artery disease	0.000355	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PDE4B—coronary artery disease	0.000354	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.000353	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000353	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—EDN1—coronary artery disease	0.000351	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PLCB3—coronary artery disease	0.000349	0.00111	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—P2RY12—coronary artery disease	0.000349	0.00111	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL5—coronary artery disease	0.000348	0.00111	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CX3CR1—coronary artery disease	0.000345	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CASR—coronary artery disease	0.000345	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HRH2—coronary artery disease	0.000342	0.00109	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB1—coronary artery disease	0.000339	0.00108	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CX3CL1—coronary artery disease	0.000339	0.00108	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GNA12—coronary artery disease	0.000339	0.00108	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PPP3R1—coronary artery disease	0.000333	0.00106	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADM—coronary artery disease	0.00033	0.00105	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR3—coronary artery disease	0.000323	0.00103	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000322	0.00102	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PDE4B—coronary artery disease	0.000321	0.00102	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000315	0.001	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RHOC—coronary artery disease	0.000311	0.000988	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ACVR1B—coronary artery disease	0.000311	0.000988	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—coronary artery disease	0.000307	0.000976	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—C3—coronary artery disease	0.000306	0.000975	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—coronary artery disease	0.000305	0.000971	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL2—coronary artery disease	0.000304	0.000968	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000303	0.000962	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NEDD4—coronary artery disease	0.000302	0.000961	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—F2R—coronary artery disease	0.000301	0.000957	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PF4—coronary artery disease	0.000294	0.000937	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDE3A—coronary artery disease	0.000294	0.000937	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MDK—coronary artery disease	0.000294	0.000937	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RAMP2—coronary artery disease	0.000294	0.000937	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR3—coronary artery disease	0.000294	0.000934	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDNRB—coronary artery disease	0.000291	0.000927	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AGT—coronary artery disease	0.000291	0.000926	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2RL1—coronary artery disease	0.000281	0.000894	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY5R—coronary artery disease	0.000281	0.000894	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RALBP1—coronary artery disease	0.000281	0.000894	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL2—coronary artery disease	0.000276	0.000879	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL3—coronary artery disease	0.000276	0.000879	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDNRA—coronary artery disease	0.000275	0.000875	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRB1—coronary artery disease	0.000274	0.000871	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—F2R—coronary artery disease	0.000273	0.000869	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FZD2—coronary artery disease	0.000269	0.000857	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—UTS2R—coronary artery disease	0.000269	0.000857	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—F2—coronary artery disease	0.000269	0.000856	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRB—coronary artery disease	0.000264	0.000841	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SFRP2—coronary artery disease	0.000264	0.00084	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADORA3—coronary artery disease	0.000259	0.000825	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOA4—coronary artery disease	0.000259	0.000825	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADORA1—coronary artery disease	0.000259	0.000825	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000259	0.000823	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL12—coronary artery disease	0.000259	0.000823	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PLCB1—coronary artery disease	0.000253	0.000805	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PGF—coronary artery disease	0.00025	0.000796	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PPBP—coronary artery disease	0.00025	0.000796	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRA—coronary artery disease	0.00025	0.000795	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000249	0.000792	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—ADRB1—coronary artery disease	0.000249	0.000791	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR7—coronary artery disease	0.000248	0.000788	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DVL1—coronary artery disease	0.000246	0.000784	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ITGA2B—coronary artery disease	0.000246	0.000784	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	0.000246	0.000782	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—coronary artery disease	0.000245	0.00078	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—coronary artery disease	0.000244	0.000777	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—coronary artery disease	0.00024	0.000763	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL4—coronary artery disease	0.000239	0.00076	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GHR—coronary artery disease	0.000239	0.00076	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—OPRD1—coronary artery disease	0.000239	0.00076	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—PIK3CA—coronary artery disease	0.000239	0.000759	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—KNG1—coronary artery disease	0.000235	0.000748	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—coronary artery disease	0.000235	0.000747	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL12—coronary artery disease	0.000235	0.000747	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR1—coronary artery disease	0.000234	0.000744	CbGpPWpGaD
Fosaprepitant—Dry mouth—Ramipril—coronary artery disease	0.000231	0.000376	CcSEcCtD
Fosaprepitant—Chest pain—Timolol—coronary artery disease	0.00023	0.000376	CcSEcCtD
Fosaprepitant—Vomiting—Ezetimibe—coronary artery disease	0.00023	0.000375	CcSEcCtD
Fosaprepitant—Hypersensitivity—Pravastatin—coronary artery disease	0.00023	0.000375	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Perindopril—coronary artery disease	0.00023	0.000375	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—PLCB1—coronary artery disease	0.00023	0.000731	CbGpPWpGaD
Fosaprepitant—Anxiety—Timolol—coronary artery disease	0.00023	0.000375	CcSEcCtD
Fosaprepitant—Angioedema—Lisinopril—coronary artery disease	0.000229	0.000374	CcSEcCtD
Fosaprepitant—Pruritus—Olmesartan—coronary artery disease	0.000229	0.000374	CcSEcCtD
Fosaprepitant—Decreased appetite—Losartan—coronary artery disease	0.000229	0.000374	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—MEF2A—coronary artery disease	0.000229	0.000728	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TLE4—coronary artery disease	0.000229	0.000728	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000229	0.000373	CcSEcCtD
Fosaprepitant—Abdominal pain—Captopril—coronary artery disease	0.000229	0.000373	CcSEcCtD
Fosaprepitant—Body temperature increased—Captopril—coronary artery disease	0.000229	0.000373	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—coronary artery disease	0.000229	0.000727	CbGpPWpGaD
Fosaprepitant—Dizziness—Simvastatin—coronary artery disease	0.000228	0.000372	CcSEcCtD
Fosaprepitant—Rash—Ezetimibe—coronary artery disease	0.000228	0.000372	CcSEcCtD
Fosaprepitant—Dermatitis—Ezetimibe—coronary artery disease	0.000228	0.000372	CcSEcCtD
Fosaprepitant—Discomfort—Timolol—coronary artery disease	0.000228	0.000371	CcSEcCtD
Fosaprepitant—Asthenia—Niacin—coronary artery disease	0.000227	0.000371	CcSEcCtD
Fosaprepitant—Fatigue—Losartan—coronary artery disease	0.000227	0.000371	CcSEcCtD
Fosaprepitant—Headache—Ezetimibe—coronary artery disease	0.000227	0.00037	CcSEcCtD
Fosaprepitant—Malaise—Lisinopril—coronary artery disease	0.000226	0.000369	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Ramipril—coronary artery disease	0.000226	0.000369	CcSEcCtD
Fosaprepitant—Oedema—Ramipril—coronary artery disease	0.000226	0.000369	CcSEcCtD
Fosaprepitant—Dry mouth—Timolol—coronary artery disease	0.000225	0.000368	CcSEcCtD
Fosaprepitant—Pain—Losartan—coronary artery disease	0.000225	0.000368	CcSEcCtD
Fosaprepitant—Constipation—Losartan—coronary artery disease	0.000225	0.000368	CcSEcCtD
Fosaprepitant—Syncope—Lisinopril—coronary artery disease	0.000225	0.000367	CcSEcCtD
Fosaprepitant—Vomiting—Eplerenone—coronary artery disease	0.000225	0.000367	CcSEcCtD
Fosaprepitant—Feeling abnormal—Furosemide—coronary artery disease	0.000225	0.000367	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR7—coronary artery disease	0.000225	0.000715	CbGpPWpGaD
Fosaprepitant—Nausea—Fenofibrate—coronary artery disease	0.000224	0.000366	CcSEcCtD
Fosaprepitant—Pruritus—Niacin—coronary artery disease	0.000224	0.000366	CcSEcCtD
Fosaprepitant—Asthenia—Pravastatin—coronary artery disease	0.000224	0.000365	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Furosemide—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—Rash—Eplerenone—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—Urticaria—Perindopril—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—Hypersensitivity—Trandolapril—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—APOA2—coronary artery disease	0.000223	0.00071	CbGpPWpGaD
Fosaprepitant—Dermatitis—Eplerenone—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—Diarrhoea—Valsartan—coronary artery disease	0.000223	0.000364	CcSEcCtD
Fosaprepitant—Shock—Ramipril—coronary artery disease	0.000222	0.000363	CcSEcCtD
Fosaprepitant—Hypersensitivity—Enalapril—coronary artery disease	0.000222	0.000363	CcSEcCtD
Fosaprepitant—Body temperature increased—Perindopril—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—Abdominal pain—Perindopril—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—Palpitations—Lisinopril—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—ADRB2—coronary artery disease	0.000222	0.000706	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Olmesartan—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—Headache—Eplerenone—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—Nervous system disorder—Ramipril—coronary artery disease	0.000222	0.000362	CcSEcCtD
Fosaprepitant—Oedema—Timolol—coronary artery disease	0.000221	0.00036	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Timolol—coronary artery disease	0.000221	0.00036	CcSEcCtD
Fosaprepitant—Pruritus—Pravastatin—coronary artery disease	0.000221	0.00036	CcSEcCtD
Fosaprepitant—Loss of consciousness—Lisinopril—coronary artery disease	0.000221	0.00036	CcSEcCtD
Fosaprepitant—Nausea—Clopidogrel—coronary artery disease	0.000221	0.00036	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—AVPR1A—coronary artery disease	0.00022	0.000701	CbGpPWpGaD
Fosaprepitant—Skin disorder—Ramipril—coronary artery disease	0.000219	0.000358	CcSEcCtD
Fosaprepitant—Infection—Timolol—coronary artery disease	0.000219	0.000358	CcSEcCtD
Fosaprepitant—Vomiting—Simvastatin—coronary artery disease	0.000219	0.000358	CcSEcCtD
Fosaprepitant—Hypersensitivity—Telmisartan—coronary artery disease	0.000219	0.000358	CcSEcCtD
Fosaprepitant—Cough—Lisinopril—coronary artery disease	0.000219	0.000357	CcSEcCtD
Fosaprepitant—Nausea—Lovastatin—coronary artery disease	0.000219	0.000357	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCE—coronary artery disease	0.000219	0.000697	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Ramipril—coronary artery disease	0.000218	0.000356	CcSEcCtD
Fosaprepitant—Rash—Simvastatin—coronary artery disease	0.000218	0.000355	CcSEcCtD
Fosaprepitant—Dermatitis—Simvastatin—coronary artery disease	0.000217	0.000355	CcSEcCtD
Fosaprepitant—Asthenia—Trandolapril—coronary artery disease	0.000217	0.000355	CcSEcCtD
Fosaprepitant—Shock—Timolol—coronary artery disease	0.000217	0.000355	CcSEcCtD
Fosaprepitant—Feeling abnormal—Losartan—coronary artery disease	0.000217	0.000354	CcSEcCtD
Fosaprepitant—Urticaria—Furosemide—coronary artery disease	0.000217	0.000354	CcSEcCtD
Fosaprepitant—Diarrhoea—Niacin—coronary artery disease	0.000217	0.000354	CcSEcCtD
Fosaprepitant—Nervous system disorder—Timolol—coronary artery disease	0.000217	0.000353	CcSEcCtD
Fosaprepitant—Asthenia—Enalapril—coronary artery disease	0.000216	0.000353	CcSEcCtD
Fosaprepitant—Headache—Simvastatin—coronary artery disease	0.000216	0.000353	CcSEcCtD
Fosaprepitant—Abdominal pain—Furosemide—coronary artery disease	0.000216	0.000352	CcSEcCtD
Fosaprepitant—Body temperature increased—Furosemide—coronary artery disease	0.000216	0.000352	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Losartan—coronary artery disease	0.000215	0.000352	CcSEcCtD
Fosaprepitant—Dizziness—Valsartan—coronary artery disease	0.000215	0.000352	CcSEcCtD
Fosaprepitant—Nausea—Ezetimibe—coronary artery disease	0.000215	0.000351	CcSEcCtD
Fosaprepitant—Skin disorder—Timolol—coronary artery disease	0.000215	0.00035	CcSEcCtD
Fosaprepitant—Dizziness—Olmesartan—coronary artery disease	0.000214	0.00035	CcSEcCtD
Fosaprepitant—Pruritus—Trandolapril—coronary artery disease	0.000214	0.00035	CcSEcCtD
Fosaprepitant—Chest pain—Lisinopril—coronary artery disease	0.000214	0.000349	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—KNG1—coronary artery disease	0.000214	0.00068	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Timolol—coronary artery disease	0.000214	0.000348	CcSEcCtD
Fosaprepitant—Asthenia—Telmisartan—coronary artery disease	0.000213	0.000348	CcSEcCtD
Fosaprepitant—Pruritus—Enalapril—coronary artery disease	0.000213	0.000348	CcSEcCtD
Fosaprepitant—Diarrhoea—Pravastatin—coronary artery disease	0.000213	0.000348	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000213	0.000679	CbGpPWpGaD
Fosaprepitant—Anxiety—Lisinopril—coronary artery disease	0.000213	0.000348	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—UTS2—coronary artery disease	0.000213	0.000677	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR1—coronary artery disease	0.000212	0.000676	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000212	0.000346	CcSEcCtD
Fosaprepitant—Discomfort—Lisinopril—coronary artery disease	0.000211	0.000345	CcSEcCtD
Fosaprepitant—Hypotension—Ramipril—coronary artery disease	0.000211	0.000344	CcSEcCtD
Fosaprepitant—Pruritus—Telmisartan—coronary artery disease	0.000211	0.000343	CcSEcCtD
Fosaprepitant—Nausea—Eplerenone—coronary artery disease	0.00021	0.000343	CcSEcCtD
Fosaprepitant—Dizziness—Niacin—coronary artery disease	0.000209	0.000342	CcSEcCtD
Fosaprepitant—Urticaria—Losartan—coronary artery disease	0.000209	0.000342	CcSEcCtD
Fosaprepitant—Dry mouth—Lisinopril—coronary artery disease	0.000209	0.000341	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NR4A1—coronary artery disease	0.000208	0.000663	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Losartan—coronary artery disease	0.000208	0.00034	CcSEcCtD
Fosaprepitant—Body temperature increased—Losartan—coronary artery disease	0.000208	0.00034	CcSEcCtD
Fosaprepitant—Asthenia—Captopril—coronary artery disease	0.000208	0.000339	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—coronary artery disease	0.000208	0.00066	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Trandolapril—coronary artery disease	0.000207	0.000338	CcSEcCtD
Fosaprepitant—Vomiting—Valsartan—coronary artery disease	0.000207	0.000338	CcSEcCtD
Fosaprepitant—Diarrhoea—Enalapril—coronary artery disease	0.000206	0.000337	CcSEcCtD
Fosaprepitant—Hypotension—Timolol—coronary artery disease	0.000206	0.000337	CcSEcCtD
Fosaprepitant—Dizziness—Pravastatin—coronary artery disease	0.000206	0.000337	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PLCB3—coronary artery disease	0.000206	0.000656	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HDAC9—coronary artery disease	0.000206	0.000656	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—P2RY12—coronary artery disease	0.000206	0.000656	CbGpPWpGaD
Fosaprepitant—Vomiting—Olmesartan—coronary artery disease	0.000206	0.000336	CcSEcCtD
Fosaprepitant—Rash—Valsartan—coronary artery disease	0.000205	0.000335	CcSEcCtD
Fosaprepitant—Dermatitis—Valsartan—coronary artery disease	0.000205	0.000335	CcSEcCtD
Fosaprepitant—Nausea—Simvastatin—coronary artery disease	0.000205	0.000334	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Lisinopril—coronary artery disease	0.000205	0.000334	CcSEcCtD
Fosaprepitant—Oedema—Lisinopril—coronary artery disease	0.000205	0.000334	CcSEcCtD
Fosaprepitant—Pruritus—Captopril—coronary artery disease	0.000205	0.000334	CcSEcCtD
Fosaprepitant—Rash—Olmesartan—coronary artery disease	0.000204	0.000334	CcSEcCtD
Fosaprepitant—Insomnia—Ramipril—coronary artery disease	0.000204	0.000333	CcSEcCtD
Fosaprepitant—Dermatitis—Olmesartan—coronary artery disease	0.000204	0.000333	CcSEcCtD
Fosaprepitant—Headache—Valsartan—coronary artery disease	0.000204	0.000333	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CX3CR1—coronary artery disease	0.000204	0.000649	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASR—coronary artery disease	0.000204	0.000649	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Telmisartan—coronary artery disease	0.000204	0.000332	CcSEcCtD
Fosaprepitant—Infection—Lisinopril—coronary artery disease	0.000204	0.000332	CcSEcCtD
Fosaprepitant—Headache—Olmesartan—coronary artery disease	0.000203	0.000331	CcSEcCtD
Fosaprepitant—Shock—Lisinopril—coronary artery disease	0.000202	0.000329	CcSEcCtD
Fosaprepitant—Asthenia—Perindopril—coronary artery disease	0.000202	0.000329	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—ADRB2—coronary artery disease	0.000201	0.000641	CbGpPWpGaD
Fosaprepitant—Dyspnoea—Ramipril—coronary artery disease	0.000201	0.000329	CcSEcCtD
Fosaprepitant—Vomiting—Niacin—coronary artery disease	0.000201	0.000329	CcSEcCtD
Fosaprepitant—Hypersensitivity—Furosemide—coronary artery disease	0.000201	0.000328	CcSEcCtD
Fosaprepitant—Somnolence—Ramipril—coronary artery disease	0.000201	0.000328	CcSEcCtD
Fosaprepitant—Dizziness—Trandolapril—coronary artery disease	0.0002	0.000327	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—P4HB—coronary artery disease	0.0002	0.000637	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNA12—coronary artery disease	0.0002	0.000637	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB1—coronary artery disease	0.0002	0.000637	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CX3CL1—coronary artery disease	0.0002	0.000637	CbGpPWpGaD
Fosaprepitant—Insomnia—Timolol—coronary artery disease	0.0002	0.000326	CcSEcCtD
Fosaprepitant—Rash—Niacin—coronary artery disease	0.0002	0.000326	CcSEcCtD
Fosaprepitant—Dermatitis—Niacin—coronary artery disease	0.0002	0.000326	CcSEcCtD
Fosaprepitant—Dizziness—Enalapril—coronary artery disease	0.000199	0.000325	CcSEcCtD
Fosaprepitant—Skin disorder—Lisinopril—coronary artery disease	0.000199	0.000325	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCE—coronary artery disease	0.000199	0.000633	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Ramipril—coronary artery disease	0.000199	0.000325	CcSEcCtD
Fosaprepitant—Pruritus—Perindopril—coronary artery disease	0.000199	0.000324	CcSEcCtD
Fosaprepitant—Headache—Niacin—coronary artery disease	0.000198	0.000324	CcSEcCtD
Fosaprepitant—Vomiting—Pravastatin—coronary artery disease	0.000198	0.000324	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—EDN1—coronary artery disease	0.000198	0.000631	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Lisinopril—coronary artery disease	0.000198	0.000323	CcSEcCtD
Fosaprepitant—Diarrhoea—Captopril—coronary artery disease	0.000198	0.000323	CcSEcCtD
Fosaprepitant—Dyspnoea—Timolol—coronary artery disease	0.000197	0.000321	CcSEcCtD
Fosaprepitant—Dizziness—Telmisartan—coronary artery disease	0.000197	0.000321	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—coronary artery disease	0.000197	0.000626	CbGpPWpGaD
Fosaprepitant—Rash—Pravastatin—coronary artery disease	0.000197	0.000321	CcSEcCtD
Fosaprepitant—Dermatitis—Pravastatin—coronary artery disease	0.000196	0.000321	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PPP3R1—coronary artery disease	0.000196	0.000625	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Ramipril—coronary artery disease	0.000196	0.00032	CcSEcCtD
Fosaprepitant—Somnolence—Timolol—coronary artery disease	0.000196	0.00032	CcSEcCtD
Fosaprepitant—Asthenia—Furosemide—coronary artery disease	0.000196	0.00032	CcSEcCtD
Fosaprepitant—Headache—Pravastatin—coronary artery disease	0.000195	0.000319	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000195	0.000318	CcSEcCtD
Fosaprepitant—Fatigue—Ramipril—coronary artery disease	0.000195	0.000318	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADM—coronary artery disease	0.000195	0.000619	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Timolol—coronary artery disease	0.000194	0.000317	CcSEcCtD
Fosaprepitant—Hypersensitivity—Losartan—coronary artery disease	0.000194	0.000317	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CSF2—coronary artery disease	0.000194	0.000616	CbGpPWpGaD
Fosaprepitant—Nausea—Valsartan—coronary artery disease	0.000194	0.000316	CcSEcCtD
Fosaprepitant—Pruritus—Furosemide—coronary artery disease	0.000193	0.000315	CcSEcCtD
Fosaprepitant—Constipation—Ramipril—coronary artery disease	0.000193	0.000315	CcSEcCtD
Fosaprepitant—Nausea—Olmesartan—coronary artery disease	0.000193	0.000314	CcSEcCtD
Fosaprepitant—Vomiting—Trandolapril—coronary artery disease	0.000193	0.000314	CcSEcCtD
Fosaprepitant—Diarrhoea—Perindopril—coronary artery disease	0.000192	0.000314	CcSEcCtD
Fosaprepitant—Decreased appetite—Timolol—coronary artery disease	0.000192	0.000313	CcSEcCtD
Fosaprepitant—Vomiting—Enalapril—coronary artery disease	0.000192	0.000313	CcSEcCtD
Fosaprepitant—Hypotension—Lisinopril—coronary artery disease	0.000191	0.000312	CcSEcCtD
Fosaprepitant—Dizziness—Captopril—coronary artery disease	0.000191	0.000312	CcSEcCtD
Fosaprepitant—Rash—Trandolapril—coronary artery disease	0.000191	0.000312	CcSEcCtD
Fosaprepitant—Dermatitis—Trandolapril—coronary artery disease	0.000191	0.000311	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Timolol—coronary artery disease	0.000191	0.000311	CcSEcCtD
Fosaprepitant—Fatigue—Timolol—coronary artery disease	0.00019	0.000311	CcSEcCtD
Fosaprepitant—Rash—Enalapril—coronary artery disease	0.00019	0.00031	CcSEcCtD
Fosaprepitant—Dermatitis—Enalapril—coronary artery disease	0.00019	0.00031	CcSEcCtD
Fosaprepitant—Headache—Trandolapril—coronary artery disease	0.00019	0.00031	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PDE4B—coronary artery disease	0.00019	0.000604	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CYBB—coronary artery disease	0.00019	0.000604	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—coronary artery disease	0.00019	0.000603	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—MMP3—coronary artery disease	0.000189	0.000602	CbGpPWpGaD
Fosaprepitant—Vomiting—Telmisartan—coronary artery disease	0.000189	0.000309	CcSEcCtD
Fosaprepitant—Asthenia—Losartan—coronary artery disease	0.000189	0.000308	CcSEcCtD
Fosaprepitant—Headache—Enalapril—coronary artery disease	0.000189	0.000308	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000189	0.000601	CbGpPWpGaD
Fosaprepitant—Pain—Timolol—coronary artery disease	0.000189	0.000308	CcSEcCtD
Fosaprepitant—Nausea—Niacin—coronary artery disease	0.000188	0.000307	CcSEcCtD
Fosaprepitant—Rash—Telmisartan—coronary artery disease	0.000188	0.000306	CcSEcCtD
Fosaprepitant—Dermatitis—Telmisartan—coronary artery disease	0.000187	0.000306	CcSEcCtD
Fosaprepitant—Diarrhoea—Furosemide—coronary artery disease	0.000187	0.000305	CcSEcCtD
Fosaprepitant—Pruritus—Losartan—coronary artery disease	0.000186	0.000304	CcSEcCtD
Fosaprepitant—Headache—Telmisartan—coronary artery disease	0.000186	0.000304	CcSEcCtD
Fosaprepitant—Feeling abnormal—Ramipril—coronary artery disease	0.000186	0.000304	CcSEcCtD
Fosaprepitant—Dizziness—Perindopril—coronary artery disease	0.000186	0.000303	CcSEcCtD
Fosaprepitant—Insomnia—Lisinopril—coronary artery disease	0.000185	0.000302	CcSEcCtD
Fosaprepitant—Nausea—Pravastatin—coronary artery disease	0.000185	0.000302	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Ramipril—coronary artery disease	0.000185	0.000301	CcSEcCtD
Fosaprepitant—Vomiting—Captopril—coronary artery disease	0.000184	0.0003	CcSEcCtD
Fosaprepitant—Dyspnoea—Lisinopril—coronary artery disease	0.000183	0.000298	CcSEcCtD
Fosaprepitant—Rash—Captopril—coronary artery disease	0.000182	0.000298	CcSEcCtD
Fosaprepitant—Dermatitis—Captopril—coronary artery disease	0.000182	0.000297	CcSEcCtD
Fosaprepitant—Somnolence—Lisinopril—coronary artery disease	0.000182	0.000297	CcSEcCtD
Fosaprepitant—Feeling abnormal—Timolol—coronary artery disease	0.000182	0.000297	CcSEcCtD
Fosaprepitant—Headache—Captopril—coronary artery disease	0.000181	0.000296	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Timolol—coronary artery disease	0.000181	0.000295	CcSEcCtD
Fosaprepitant—Dizziness—Furosemide—coronary artery disease	0.000181	0.000295	CcSEcCtD
Fosaprepitant—Dyspepsia—Lisinopril—coronary artery disease	0.00018	0.000294	CcSEcCtD
Fosaprepitant—Diarrhoea—Losartan—coronary artery disease	0.00018	0.000294	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—EDN1—coronary artery disease	0.00018	0.000573	CbGpPWpGaD
Fosaprepitant—Nausea—Trandolapril—coronary artery disease	0.00018	0.000294	CcSEcCtD
Fosaprepitant—Urticaria—Ramipril—coronary artery disease	0.000179	0.000293	CcSEcCtD
Fosaprepitant—Nausea—Enalapril—coronary artery disease	0.000179	0.000292	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—coronary artery disease	0.000179	0.000568	CbGpPWpGaD
Fosaprepitant—Vomiting—Perindopril—coronary artery disease	0.000179	0.000291	CcSEcCtD
Fosaprepitant—Abdominal pain—Ramipril—coronary artery disease	0.000179	0.000291	CcSEcCtD
Fosaprepitant—Body temperature increased—Ramipril—coronary artery disease	0.000179	0.000291	CcSEcCtD
Fosaprepitant—Decreased appetite—Lisinopril—coronary artery disease	0.000178	0.000291	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCD—coronary artery disease	0.000177	0.000564	CbGpPWpGaD
Fosaprepitant—Rash—Perindopril—coronary artery disease	0.000177	0.000289	CcSEcCtD
Fosaprepitant—Dermatitis—Perindopril—coronary artery disease	0.000177	0.000289	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000177	0.000289	CcSEcCtD
Fosaprepitant—Nausea—Telmisartan—coronary artery disease	0.000177	0.000288	CcSEcCtD
Fosaprepitant—Fatigue—Lisinopril—coronary artery disease	0.000177	0.000288	CcSEcCtD
Fosaprepitant—Headache—Perindopril—coronary artery disease	0.000176	0.000287	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CSF2—coronary artery disease	0.000176	0.00056	CbGpPWpGaD
Fosaprepitant—Urticaria—Timolol—coronary artery disease	0.000175	0.000286	CcSEcCtD
Fosaprepitant—Pain—Lisinopril—coronary artery disease	0.000175	0.000286	CcSEcCtD
Fosaprepitant—Constipation—Lisinopril—coronary artery disease	0.000175	0.000286	CcSEcCtD
Fosaprepitant—Abdominal pain—Timolol—coronary artery disease	0.000175	0.000285	CcSEcCtD
Fosaprepitant—Body temperature increased—Timolol—coronary artery disease	0.000175	0.000285	CcSEcCtD
Fosaprepitant—Dizziness—Losartan—coronary artery disease	0.000174	0.000284	CcSEcCtD
Fosaprepitant—Vomiting—Furosemide—coronary artery disease	0.000174	0.000283	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR3—coronary artery disease	0.000174	0.000552	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—coronary artery disease	0.000173	0.000552	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—C3—coronary artery disease	0.000173	0.000551	CbGpPWpGaD
Fosaprepitant—Rash—Furosemide—coronary artery disease	0.000172	0.000281	CcSEcCtD
Fosaprepitant—Dermatitis—Furosemide—coronary artery disease	0.000172	0.000281	CcSEcCtD
Fosaprepitant—Nausea—Captopril—coronary artery disease	0.000172	0.00028	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CRK—coronary artery disease	0.000171	0.000545	CbGpPWpGaD
Fosaprepitant—Headache—Furosemide—coronary artery disease	0.000171	0.000279	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SH2B3—coronary artery disease	0.000169	0.000538	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ATP2A2—coronary artery disease	0.000169	0.000538	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VWF—coronary artery disease	0.000169	0.000538	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Lisinopril—coronary artery disease	0.000169	0.000276	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—APOC3—coronary artery disease	0.000168	0.000535	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000168	0.000273	CcSEcCtD
Fosaprepitant—Vomiting—Losartan—coronary artery disease	0.000168	0.000273	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LDLR—coronary artery disease	0.000167	0.000531	CbGpPWpGaD
Fosaprepitant—Nausea—Perindopril—coronary artery disease	0.000167	0.000272	CcSEcCtD
Fosaprepitant—Hypersensitivity—Ramipril—coronary artery disease	0.000166	0.000272	CcSEcCtD
Fosaprepitant—Rash—Losartan—coronary artery disease	0.000166	0.000271	CcSEcCtD
Fosaprepitant—Dermatitis—Losartan—coronary artery disease	0.000166	0.000271	CcSEcCtD
Fosaprepitant—Headache—Losartan—coronary artery disease	0.000165	0.000269	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—AGT—coronary artery disease	0.000165	0.000524	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PPP2CA—coronary artery disease	0.000164	0.000521	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL2—coronary artery disease	0.000163	0.000519	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL3—coronary artery disease	0.000163	0.000519	CbGpPWpGaD
Fosaprepitant—Urticaria—Lisinopril—coronary artery disease	0.000163	0.000266	CcSEcCtD
Fosaprepitant—Hypersensitivity—Timolol—coronary artery disease	0.000163	0.000266	CcSEcCtD
Fosaprepitant—Nausea—Furosemide—coronary artery disease	0.000162	0.000265	CcSEcCtD
Fosaprepitant—Asthenia—Ramipril—coronary artery disease	0.000162	0.000264	CcSEcCtD
Fosaprepitant—Abdominal pain—Lisinopril—coronary artery disease	0.000162	0.000264	CcSEcCtD
Fosaprepitant—Body temperature increased—Lisinopril—coronary artery disease	0.000162	0.000264	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SDC1—coronary artery disease	0.000161	0.000513	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2R—coronary artery disease	0.000161	0.000513	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCD—coronary artery disease	0.000161	0.000512	CbGpPWpGaD
Fosaprepitant—Pruritus—Ramipril—coronary artery disease	0.00016	0.000261	CcSEcCtD
Fosaprepitant—Asthenia—Timolol—coronary artery disease	0.000158	0.000259	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—FGB—coronary artery disease	0.000158	0.000502	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—coronary artery disease	0.000158	0.000501	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—C3—coronary artery disease	0.000157	0.0005	CbGpPWpGaD
Fosaprepitant—Nausea—Losartan—coronary artery disease	0.000157	0.000255	CcSEcCtD
Fosaprepitant—Pruritus—Timolol—coronary artery disease	0.000156	0.000255	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—EDNRB—coronary artery disease	0.000156	0.000497	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Ramipril—coronary artery disease	0.000155	0.000252	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—THBS1—coronary artery disease	0.000154	0.00049	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSMA6—coronary artery disease	0.000152	0.000485	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSMB5—coronary artery disease	0.000152	0.000485	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—F2—coronary artery disease	0.000152	0.000484	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Timolol—coronary artery disease	0.000151	0.000247	CcSEcCtD
Fosaprepitant—Hypersensitivity—Lisinopril—coronary artery disease	0.000151	0.000246	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—AGT—coronary artery disease	0.000149	0.000475	CbGpPWpGaD
Fosaprepitant—Dizziness—Ramipril—coronary artery disease	0.000149	0.000244	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—EDNRA—coronary artery disease	0.000148	0.000469	CbGpPWpGaD
Fosaprepitant—Asthenia—Lisinopril—coronary artery disease	0.000147	0.00024	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CYBA—coronary artery disease	0.000147	0.000467	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADRB1—coronary artery disease	0.000147	0.000467	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DUSP6—coronary artery disease	0.000146	0.000465	CbGpPWpGaD
Fosaprepitant—Dizziness—Timolol—coronary artery disease	0.000146	0.000238	CcSEcCtD
Fosaprepitant—Pruritus—Lisinopril—coronary artery disease	0.000145	0.000237	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PLAT—coronary artery disease	0.000144	0.000457	CbGpPWpGaD
Fosaprepitant—Vomiting—Ramipril—coronary artery disease	0.000144	0.000234	CcSEcCtD
Fosaprepitant—Rash—Ramipril—coronary artery disease	0.000142	0.000232	CcSEcCtD
Fosaprepitant—Dermatitis—Ramipril—coronary artery disease	0.000142	0.000232	CcSEcCtD
Fosaprepitant—Headache—Ramipril—coronary artery disease	0.000142	0.000231	CcSEcCtD
Fosaprepitant—Vomiting—Timolol—coronary artery disease	0.00014	0.000229	CcSEcCtD
Fosaprepitant—Diarrhoea—Lisinopril—coronary artery disease	0.00014	0.000229	CcSEcCtD
Fosaprepitant—Rash—Timolol—coronary artery disease	0.000139	0.000227	CcSEcCtD
Fosaprepitant—Dermatitis—Timolol—coronary artery disease	0.000139	0.000227	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—coronary artery disease	0.000139	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL12—coronary artery disease	0.000139	0.000441	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—coronary artery disease	0.000139	0.000441	CbGpPWpGaD
Fosaprepitant—Headache—Timolol—coronary artery disease	0.000138	0.000226	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—F2—coronary artery disease	0.000138	0.000439	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6ST—coronary artery disease	0.000138	0.000438	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—JUNB—coronary artery disease	0.000136	0.000433	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLCB1—coronary artery disease	0.000136	0.000432	CbGpPWpGaD
Fosaprepitant—Dizziness—Lisinopril—coronary artery disease	0.000135	0.000221	CcSEcCtD
Fosaprepitant—Nausea—Ramipril—coronary artery disease	0.000134	0.000219	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR7—coronary artery disease	0.000133	0.000423	CbGpPWpGaD
Fosaprepitant—Nausea—Timolol—coronary artery disease	0.000131	0.000214	CcSEcCtD
Fosaprepitant—Vomiting—Lisinopril—coronary artery disease	0.00013	0.000213	CcSEcCtD
Fosaprepitant—Rash—Lisinopril—coronary artery disease	0.000129	0.000211	CcSEcCtD
Fosaprepitant—Dermatitis—Lisinopril—coronary artery disease	0.000129	0.000211	CcSEcCtD
Fosaprepitant—Headache—Lisinopril—coronary artery disease	0.000128	0.000209	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ITGAV—coronary artery disease	0.000127	0.000403	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KNG1—coronary artery disease	0.000126	0.000401	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—coronary artery disease	0.000126	0.0004	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CREB1—coronary artery disease	0.000126	0.0004	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR1—coronary artery disease	0.000125	0.000399	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—coronary artery disease	0.000123	0.000392	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6R—coronary artery disease	0.000123	0.00039	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—coronary artery disease	0.000123	0.00039	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLG—coronary artery disease	0.000122	0.000389	CbGpPWpGaD
Fosaprepitant—Nausea—Lisinopril—coronary artery disease	0.000122	0.000199	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ADRB2—coronary artery disease	0.000119	0.000379	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCE—coronary artery disease	0.000118	0.000374	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—JAK2—coronary artery disease	0.000117	0.000373	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SOCS1—coronary artery disease	0.000117	0.000373	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—S100B—coronary artery disease	0.000117	0.000372	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SOCS3—coronary artery disease	0.000116	0.000368	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KITLG—coronary artery disease	0.000114	0.000364	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFBR2—coronary artery disease	0.000114	0.000364	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT5A—coronary artery disease	0.000112	0.000356	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP3—coronary artery disease	0.000112	0.000356	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOB—coronary artery disease	0.000108	0.000344	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—coronary artery disease	0.000107	0.000341	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—JAK2—coronary artery disease	0.000107	0.000339	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDN1—coronary artery disease	0.000106	0.000338	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—coronary artery disease	0.000106	0.000336	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGF1—coronary artery disease	0.000104	0.000331	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CSF2—coronary artery disease	0.000104	0.000331	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LPL—coronary artery disease	0.000103	0.000328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RPS6KB1—coronary artery disease	0.000102	0.000325	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MEF2C—coronary artery disease	0.000102	0.000325	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ITGB3—coronary artery disease	9.97e-05	0.000317	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—coronary artery disease	9.73e-05	0.00031	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PPP2CA—coronary artery disease	9.68e-05	0.000308	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCD—coronary artery disease	9.51e-05	0.000302	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—coronary artery disease	9.3e-05	0.000296	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3—coronary artery disease	9.29e-05	0.000296	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HIF1A—coronary artery disease	8.86e-05	0.000282	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGT—coronary artery disease	8.83e-05	0.000281	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LEP—coronary artery disease	8.65e-05	0.000275	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOE—coronary artery disease	8.65e-05	0.000275	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOA1—coronary artery disease	8.55e-05	0.000272	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KDR—coronary artery disease	8.47e-05	0.00027	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK14—coronary artery disease	8.42e-05	0.000268	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ESR1—coronary artery disease	8.26e-05	0.000263	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FN1—coronary artery disease	8.16e-05	0.00026	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2—coronary artery disease	8.16e-05	0.00026	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6ST—coronary artery disease	8.12e-05	0.000258	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NFKBIA—coronary artery disease	8.06e-05	0.000256	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KIT—coronary artery disease	7.81e-05	0.000248	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GSK3B—coronary artery disease	7.49e-05	0.000238	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CREB1—coronary artery disease	7.43e-05	0.000236	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—coronary artery disease	7.43e-05	0.000236	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—coronary artery disease	7.27e-05	0.000231	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6R—coronary artery disease	7.25e-05	0.000231	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1—coronary artery disease	7.15e-05	0.000227	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—MAPK1—coronary artery disease	7.11e-05	0.000226	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.8e-05	0.000216	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SERPINE1—coronary artery disease	6.79e-05	0.000216	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGF2—coronary artery disease	6.57e-05	0.000209	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—coronary artery disease	6.48e-05	0.000206	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—JAK2—coronary artery disease	6.3e-05	0.0002	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3CA—coronary artery disease	6.17e-05	0.000196	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—coronary artery disease	5.75e-05	0.000183	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT1—coronary artery disease	5.55e-05	0.000177	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASP3—coronary artery disease	5.5e-05	0.000175	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—coronary artery disease	5.47e-05	0.000174	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCND1—coronary artery disease	5.36e-05	0.00017	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—coronary artery disease	5.2e-05	0.000165	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT1—coronary artery disease	5.04e-05	0.00016	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—coronary artery disease	4.67e-05	0.000149	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—coronary artery disease	4.29e-05	0.000136	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK1—coronary artery disease	4.2e-05	0.000134	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3CA—coronary artery disease	3.65e-05	0.000116	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—coronary artery disease	3.23e-05	0.000103	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT1—coronary artery disease	2.98e-05	9.48e-05	CbGpPWpGaD
